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ABSTRACT
Heat shock induces the transcriptional activation of
large heterochromatic regions of the human genome
composed of arrays of satellite III DNA repeats. A num-
ber of RNA-processing factors, among them splicing
factor SF2/ASF, associate with these transcription
factors giving rise to nuclear stress bodies (nSBs).
Here, we show that the recruitment of SF2/ASF to
these structures ismediated by its second RNA recog-
nition motif. Amino acid substitutions in the first
a-helix of this domain, but not in the b-strand regions,
abrogate the association with nSBs. The same muta-
tions drastically affect the in vivo activity of SF2/ASF
in the alternative splicing of adenoviral E1A tran-
scripts. Sequence analysis identifies four putative
high-affinity binding sites for SF2/ASF in the
transcribed strand of the satellite III DNA. We have
verified by gel mobility shift assays that the second
RNA-binding domain of SF2/ASF binds at least one of
these sites. Our analysis suggests that the recruit-
ment of SF2/ASF to nSBs is mediated by a direct inter-
action with satellite III transcripts and points to the
second RNA-binding domain of the protein as the
major determinant of this interaction.
INTRODUCTION
Exposure to a variety of physical and chemical stresses pro-
foundly affects the gene expression programme and the orga-
nization of the cells. To cope with the deleterious effects of
these changes, cells activate the expression of heat-shock pro-
teins, a group of molecular chaperons that protect against the
accumulation of non-native proteins (1,2). The key player in
this response is the heat-shock transcription factor 1 (HSF1)
which, upon activation, binds to specific DNA sequences,
called heat-shock elements (HSE), in the promoters of heat-
shock genes. The activation of HSF1 involves a complex multi-
step pathway in which the inert monomer oligomerizes to a
DNA-binding, transcriptionally active trimer that relocalizes
within the nucleus [for a review see (3)]. In human cells,
activation of HSF1 is also accompanied by the accumulation
of this transcription factor in novel sub-nuclear compartments,
called nuclear stress bodies (nSBs) that transiently appear in
stressed cells (4,5). While the function of these bodies is still a
matter of investigation, a great deal of data have been recently
obtained concerning their structure and dynamics. The nSBs
are assembled on to the pericentromeric heterochromatic
regions of specific human chromosomes, among them the
extended q12 band of chromosome 9 (6,7). Assembly of
nSBs on the 9q12 band is initiated by the interaction of
HSF1 with HSE-like motifs in the satellite III repeats that
compose most of this heterochromatic region (6). Upon
binding, HSF1 directs the recruitment of the histone acetytrans-
ferase CREB-binding protein (8) that accounts for the stress-
induced accumulation of acetylated histones within nSBs (8,9).
This leads to the transcriptional activation of these heterochro-
matic regions and to the production of RNA molecules that are
complementary to the satellite III repeats by RNA polymerase
II (SatIII transcripts) (8,9). The characterization of these RNAs
is still not complete, however, it appears that they derive from
the transcription of only one strand, and that they are apparently
never exported to the cytoplasm but remain associated with the
sites of transcription (8,9). Concomitant with the synthesis of
SatIII transcripts, a number of RNA-binding proteins involved
in pre-mRNA processing accumulates within nSBs (10). These
include two hnRNP proteins (HAP and M), two members of the
SR family of splicing regulators (SF2/ASF and SRp30c) and
Sam68, a protein that links RNA processing to the signal trans-
duction cascade.
Alternative splicing of pre-mRNA is a versatile regulatory
mechanism of gene expression in eukaryotes (11,12). A large
number of studies in the last few years have elucidated the
basic elements governing alternative splice site choice. In
addition to the classical splicing signals, accessory elements
located within the recognized exon or the flanking introns can
either stimulate (enhancer) or repress (silencer) exon defini-
tion (13). The best-characterized splicing enhancers are typi-
cally purine-rich and function by binding one or more SR
proteins [for a review see (14)]. SR factors are essential
splicing factors and also regulate alternative splicing of
many pre-mRNAs. They are modular proteins formed by
one or more RNA recognition motifs (RRMs) and by a
trans-activation domain that is rich in RS dipeptides (15).
High-affinity RNA binders for some SR proteins have been
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identified using different approaches and shown to act as
splicing enhancers when introduced in the reporter genes
(16–18). The level of RNA-processing factors is known to
control the alternative splicing pattern of transcripts. In par-
ticular, the relative concentration of splicing factor SF2/ASF,
which is recruited to nSBs (10), and of its antagonistic factor
hnRNP A1, whose distribution is not affected by stress (19),
controls the selection between alternative 50 splice sites (20–
22). We have previously shown that the association of spe-
cific splicing factors with nSBs is accompanied by a change
in the alternative splicing pattern of the adenoviral E1A
transcripts, suggesting the possibility that this redistribution
of RNA-processing factors may have a functional role in the
post-transcriptional regulation of gene expression during the
recovery from stress (10).
Given the pivotal role of SF2/ASF in splicing, we have
investigated the protein domains that control the sub-nuclear
relocation of this factor in response to thermal stress. In this
paper, we show that the second RRM of SF2/ASF is necessary
and sufficient for the recruitment to nSBs. The first a-helix of
this domain is critical for this function and for the activity of
SF2/ASF in alternative splicing. Finally, we show that RRM2
is important for the association of SF2/ASF with high-affinity
binding sites in the transcribed strand of the Satellite III
sequence. Collectively, our analysis highlights the central
role of RRM2 in the SF2/ASF function.
MATERIALS AND METHODS
Cell culture and transfection
HeLa cells were grown in Dulbecco’s modified Eagles med-
ium (Cambrex, Belgium), 10% fetal bovine serum (Sigma,
USA), 50 mg/ml gentamicin and 4 mM L-glutamine. For
heat-shock experiments, cells were incubated for 1 h at
42C in a complete medium supplemented with 10 mM
HEPES buffer (Sigma) and were allowed to recover for
1 h at 37C. HeLa cells grown on cover slips were trans-
fected with 2 mg of plasmids encoding splicing factors and,
when indicated, with 1 mg of adenovirus E1A reporter plas-
mid. Transfections were carried out using the Lipofectin
Reagent as recommended by the supplier (Invitrogen, USA).
Plasmids
The full-length cDNAs for SF2/ASF, SRp30c and SRp40 were
kindly provided by Dr Caceres (15). SR proteins and SF2/ASF
mutants were cloned in frame with the green fluorescent pro-
tein (GFP) into the pEGFP-C1 (Clontech, USA) vector or
expressed N-terminally tagged to the T7 epitope by means
of the pCGTHCFFLT7 expression vector (23). The SF2/ASF
mutants described in the text were obtained by a PCR-based
technique using PWO polymerase (Roche Molecular Bio-
chemicals, Switzerland) according to the protocol described
previously (24). Primers used in PCR were purchased from
MWG-Biotech (Germany). All plasmids were verified by
sequencing with the ‘Thermo Sequenase Cy5.5 Dye Termin-
ator Cycle Sequencing Kit’ using the ‘SEQ4x4 Personal
Sequencing System’ (Amersham Pharmacia Biotech, Sweden).
The pCMVE1A plasmid containing the E1A minigene
was a gift from Dr Chabot (22). The SF2/ASF full-length
(GST-SF2), the deletion mutants GST-SF2-DRS (amino
acids 1–193) and GST-SF2-DRRM2 (amino acids 1–248
D113–193), the second RRM (GST-RRM2, amino acids
108–193) and its mutated version (GST-RRM2[WQD-
AAA]) were all expressed in Escherichia coli as GST fusions
by sub-cloning the necessary regions of the SF2/ASF cDNA
into EcoRI–SalI sites of pGEX-4T3 vector (Amersham
Pharmacia Biotech).
Indirect immunofluorescence
Indirect immunofluorescence analysis of HeLa cells was per-
formed 24 h after transfection. The cells were washed with
PBS, fixed with 4% formaldehyde for 7 min and then per-
meabilized in 0.5% Triton X-100 in PBS for 7 min on ice.
Primary affinity-purified rabbit anti-HAP polyclonal antibody
(19) and monoclonal antibody anti-splicing factor SC-35
(Sigma) were used. Secondary antibodies were: rhodamine-
conjugated anti-rabbit immunoglobulin (IgG) goat antibody
and CyTM5 anti-mouse IgG goat antibody (Jackson Immu-
noResearch Laboratories, USA). Antibodies were diluted to a
working concentration in PBS containing 5% skimmed milk
(Difco, USA), added to the cover slips and incubated for 1 h
at 37C in a humid chamber. After staining, the coverslips
were washed three times with PBS, rinsed and mounted in
90% glycerol in PBS. Confocal microscopy was performed
with a TCS-NT digital scanning confocal microscope (Leica,
Germany) equipped with a 63·/NA = 1.32 oil immersion
objective. We used the 488 nm laser line for the excitation
of GFP (detected at 500 nm < l < 540 nm), the 543 nm laser
line for the rhodamine fluorescence (detected at l > 590 nm)
and the 633 nm laser line for the CyTM5 fluorescence
(detected at l > 650 nm). The pinhole diameter was kept
at 1 mm. Images were exported to Adobe Photoshop (Adobe
System, USA).
In vivo E1A alternative splicing
Total RNAs were extracted 24 h after transfection using the
RNeasy Kit (Qiagen, Germany) according to the protocol
recommended by the supplier. To avoid plasmid contamina-
tion, RNA samples were digested with 100 U of RNase-free
DNase I (Roche Molecular Biochemicals) for 30 min at room
temperature. The RT–PCR was performed as described pre-
viously (25). Total RNA (1 mg) was retro-transcribed with
50 U of MuLV reverse transcriptase (Perkin-Elmer Life
Science Products, USA) in a 20 ml reaction as recommended
by the supplier. Amplification reactions (50 ml) contained 2 ml
of the reverse transcription reaction, 20 pmol of primers,
2 mM MgCl2, 200 mM each dNTPs and 2.5 U of Taq
polymerase (Perkin-Elmer Life Science Products) in a
standard buffer. To quantify the amplification products,
1 mCi of [a-32P]dCTP, 3000 Ci/mmol (Amersham Pharmacia)
was added to the reactions. The primers used were E1A-569
(50-ATTATCTGCCACGGAGGTGT-30) and E1A-1315 (50-
GGATAGCAGGCGCCATTTTA-30). Amplifications were
performed for 30 cycles with the following profile: 1 min
at 94C, 1 min at 56C and 1 min and 30 s at 72C. No
amplification was detectable if the reverse transcription reac-
tion was omitted. An aliquot (10 ml) of each reaction was
loaded on to a 5% polyacrylamide gel in Tris–borate–
EDTA buffer (TBE). The bands were revealed and quantified
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with the PhosphorImager 445 SI apparatus (Molecular
Dynamics, USA) using the ImageQuant version 1.0 program
(Molecular Dynamics).
Yeast two-hybrid screening
Yeast strains, the human HeLa library and cloning vectors
were from Clontech. Library screenings and yeast manipula-
tion were carried out according to the protocol recommended
by the manufacturer. RRM2 was PCR-amplified with suitable
primers from SF2/ASF wild-type (cDNA sequence 322–579
accession no. NM_006924) or from the WQD-AAA mutant
and cloned into the EcoRI–SalI sites of pAS2.1. The
Saccharomyces cerevisiae Y190 strain was transformed
with pAS2.1-RRM2 and used as a recipient to screen a HeLa
cDNA library (Clontech, cat. no. HL4000AA). A total of
7 · 107 transformants were screened on leu, trp and his
synthetic medium containing 25 mM 3-amino-1,2,4-triazole
(Sigma). The his+ colonies were isolated and tested in the b-
galactosidase filter assay. The plasmids were isolated from
colonies plated on leu, trp+ and his+ synthetic medium con-
taining 10 mg/ml cycloheximide (Sigma) and sequenced.
Gel mobility shift assays
The synthetic RNA oligonucleotides (16 nt) used for gel mobi-
lity shift assay were as follows: SMN1, GGUUUCAGA-
CAAAAUC; SMN2, GGUUUUAGACAAAAUC; and SatIII,
GGAAUCAACACGAGUG. The RNA oligonucleotides were
provided in the stable 20-ACE protected form; deacetylation
with20-deprotectionbufferwasperformed prior touseas recom-
mended by the supplier (Dharmacon). The RNA oligonucleo-
tides were radiolabeled with [32g-P]ATP following the 50
end-labeling protocol with T4 polynucleotide kinase (Pro-
mega). Unincorporated nucleotides were removed from RNA
byusingG-25SephadexColumns(Roche).Gelshiftassayswere
performed as described previously (26) using 15 fmol of radi-
olabeled RNA oligonucleotides and 4 pmol of recombinant pro-
teins in a 20ml reaction. The samples were incubated for 20 min
at room temperature. The RNA–protein complexes were sepa-
rated from free RNA by electrophoresis through 5%native poly-
acrylamide gels in 0.5% TBE buffer. The gels were dried and
analyzed with the PhosphorImager 445 SI apparatus (Molecular
Dynamics, Sunnyvale, CA), using the ImageQuant version 1.0
program (Molecular Dynamics).
Expression and purification of GST fusion proteins
Expression and purification of all GST fusion proteins [GST-
SF2/ASF, GST-RRM2, GST-RRM2(WQD-AAA), GST-SF2-
DRS and GST-SF2-DRRM2] were performed in the same way.
Briefly, 1 liter of transformed XL1Blue cultures were induced
with 2 mM isopropyl-b-D-thiogalactopyranoside for 3 h, and
the harvested cells were lysed by sonication in PBS buffer with
1% Triton X-100. Fusion proteins were purified from the
soluble fraction by glutathione–agarose beads (Sigma) and
eluted with 20 mM glutathione, 50 mM Tris–HCl, pH 8.0.
The eluted proteins were dialyzed for 3 h against 10 mM Tris–
HCl, pH 8.0, 100 mM NaCl and concentrated for 30 min in the
same buffer containing 50% glycerol. Protein concentration
was determined by the Bradford method and was monitored
by Coomassie blue staining of SDS–polyacrylamide gels.
RESULTS
RRM2 is necessary and sufficient for the recruitment
of SF2/ASF to nuclear stress bodies
In response to thermal stress, the splicing factor SF2/ASF is
recruited to nSBs [Figure 1 and (10)]. In order to investigate
the molecular mechanisms underlying this phenomenon, we
sought to identify the protein domain involved. SF2/ASF is
composed of three different domains: (i) a canonical RRM at
the N-terminus that is followed by (ii) a protein region that is
distantly related to the RRM (called pseudo-RRM or RRM2)
and finally (iii) an extended tail rich in Ser-Arg dipeptides at
the C-terminus that is thought to mediate protein–protein inter-
actions (see Figure 1 for a scheme). These domains were,
either individually or in different combinations, overexpressed
in human HeLa cells as GFP fusions and tested for their ability
to associate after heat shock (1 h at 42C followed by 1 h of
recovery at 37C) with nSBs labeled using antibodies to
hnRNP HAP. It is worth recalling that, as shown previously
(10), the GFP by itself is unable to associate with nSBs. As
expected, GFP-SF2/ASF was efficiently recruited to nSBs
(Figure 1). Although the deletion mutants displayed a certain
level of nucleolar accumulation, association with nSBs was
clearly detectable with two constructs containing only two of
the three SF2/ASF domains, namely RRM1-RRM2 and
RRM2-SR (Figure 1). In contrast, a fusion protein (RRM1-
SR) lacking RRM2 failed to associate with nSBs pointing to
this domain as the one necessary for the redistribution of SF2/
ASF upon stress (Figure 1).
To understand whether RRM2 was sufficient for the recruit-
ment, we determined the distribution of the GFP-RRM2 fusion
in heat-shock HeLa cells. As a control, we also studied the dis-
tribution of GFP-RRM1. Upon shock, only RRM2 co-localized
with hnRNP HAP in stress bodies (Figure 1) indicating that this
domain contains all the elements necessary and sufficient for
the association with nSBs.
Mapping the protein determinants for the RRM2
function
The RRM is a highly structured domain composed of a four-
strand antiparallel b-sheets packed against two a-helices per-
pendicularly oriented (27). In this structure, two short motifs,
RNP-1 and RNP-2, are located in the central b1 and b3 strands
and make direct contacts with the RNA molecule (28)
(Figure 2A). The b-sheet constitutes an RNA-binding plat-
form, but the RNA-binding specificity mainly resides in the
variable regions of the loops that connect the b-strands and in
the terminal portions of the domain. RRM2 is an atypical
RRM-like repeat that is present in a subset of SR factors. It
lacks the conserved aromatic residues present in RNP-1 and
RNP-2 but contains all of the conserved amino acids that form
the hydrophobic core of the RRM (29). The role of this domain
is still poorly understood. Several experimental data indicate
that RRM2 is essential for the specificity of binding of SF2/
ASF to RNA (15); moreover, a role of RRM2 in protein–
protein interactions has been suggested previously (30,31).
In order to gain further insight into the function of the
RRM2 in the heat-shock-induced redistribution, we chal-
lenged a number of mutants of SF2/ASF bearing amino
acid substitution in RRM2 for their ability to associate with
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nSBs. Amino acid substitutions in these mutants (Figure 2A)
were designed not to affect the overall architecture of the
domain, as the residues selected for mutations are all surface
exposed according to the three-dimensional (3D) RRM
structures. In a group of mutants (Y-A, D-R, VV-AA and
E-R in Figure 2A), we replaced the amino acids in strands
b2 and b3 that are supposed to establish direct contacts with
the RNA molecule. In one mutant (R-A), the arginine,
Figure 1. RRM2 of SF2/ASF is necessary and sufficient for the recruitment to nSBs. (A) Scheme of the SF2/ASF protein and of the different deletion mutants.
Numbers on the right indicate the amino acid regions present in each mutant. (B) The entire SF2/ASF or the indicated deletion mutants shown in (A) were
overexpressed as GFP fusions in HeLa cells. After 40 h, the cells were heat shocked (for 1 h at 42C followed by 1 h at 37C) and immediately fixed. Cells were stained
with a polyclonal antibody to hnRNP HAP and with anti-rabbit rhodamine-conjugated goat antibody. Cells were analyzed by confocal laser microscopy to study the
distribution of the GFP protein and of hnRNP HAP. Images of the same cells were taken and merged to reveal co-localization of the two proteins in nSBs.
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immediately upstream of the putative RNP-2, was substituted
with an alanine. Instead, the last mutant (WQD-AAA) was
generated by replacing three surface residues in the heptapep-
tide that composes the first a-helix of the domain and is con-
served in all the SR proteins containing an atypical RRM.
According to the RRM model, this extended a-helix is not
involved in RNA binding but has a structural function and
could be available for protein–protein interactions. As men-
tioned earlier, the 3D structure model predicts that the WQD
residues are surface exposed, and the mutation should have
minimal impact on the overall RRM structure. This is also
reflected in our bioinformatic analyses of wild-type and WQD-
AAA mutant. A possible local perturbation originating from
the substitution of tryptophan, the predicted first residue of the
helix, with alanine should not affect our interpretation of the
mutational results. All these mutants were expressed as GFP
fusions in human HeLa cells and their distribution after the
heat shock was assessed by confocal laser microscopy and
compared with that of hnRNP HAP. None of the substitutions
introduced into the b-strand regions affected the localization
of the protein (Figure 2B). Notably, a small fraction of the
overexpressed proteins was still detectable in nuclear speckles
stained by the monoclonal antibody against splicing factor SC-
35 (see Supplementary Figure 1). Although the expression
level of the proteins may influence the extent of the
recruitment, it is worth noticing that the same phenomenon
also occurs with the endogenous protein (data not shown)
suggesting that the level or activity of the recruiting factor
could be the limiting factor for this event. Contrary to the
substitutions in the b-strands, the replacement of WQD stretch,
within the first a-helix, with three alanines completely
abrogated the recruitment to nSBs (Figure 2B) and the over-
expressed protein perfectly co-localized with splicing factor
SC-35 in nuclear speckles (Supplementary Figure 1). Thus, the
heptapeptide that forms the first part of RRM2 is crucial for the
association of SF2/ASF with nSBs.
Two-hybrid screening
The results in the previous sections are compatible with two
alternative scenarios for the redistribution of SF2/ASF upon
stress. The association with nSBs, in fact, can be due to a direct
binding either to SatIII RNAs or to another protein present
in these structures. In both cases, the interaction should be
mediated by the wild-type RRM2 and sensitive to the WQD-
AAA substitution. In order to identify proteins specifically
interacting with RRM2, we screened a human cDNA library
by the two-hybrid approach in yeast using RRM2 as a bait (see
Materials and Methods). Yeast cells stably expressing a fusion
between RRM2 and the Gal4 DNA-binding domain were
Figure 2. Effect of amino acid substitutions in RRM2 on the recruitment of SF2/ASF to the nSBs. (A) Alignment of the amino acid sequence of RRM2 in three SR
proteins recruited to nSBs. The position of RNP-1 and RNP-2 motif is indicated along with their consensus sequence. At the bottom is shown the consensus of the three
sequences and the position of the a-helices and b-sheets. Mutated amino acids are indicated in the boxes above the first line. (B) SF2/ASF mutants bearing the
indicated amino acid substitutions in RRM2 were overexpressed in HeLa cells as GFP fusions. After 40 h, the cells were heat shocked as in Figure 1B, fixed and
stained with a polyclonal antibody to hnRNP HAP and with anti-rabbit rhodamine-conjugate goat antibody. The cells were analyzed by confocal laser microscopy to
study the distribution of the GFP proteins and of hnRNP HAP. Images of the same cells were taken and merged to reveal co-localization of the two proteins in nSBs.
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transformed with a library of HeLa cell cDNAs fused to the
activation domain of Gal4. From the screening of 7 · 107
transformants, we selected a few clones in which the expres-
sion of URA3 and b-galactosidase marker genes required the
presence of both the hybrid proteins. These clones contained
the cDNAs for (i) aldolase A, a glycolytic enzyme present also
in the cell nucleus (32); (ii) fortilin, a novel antiapoptotic
protein (33); and (iii) poly(A)-binding protein PABPN1,
which in unstressed cells co-localizes with SF2/ASF in nuclear
speckles (34). Interestingly, the interaction of these proteins in
the two-hybrid assay was abrogated by the replacement of the
WQD motif in RRM2 with three alanines. However, none of
them accumulated in nSBs when overexpressed in HeLa cells
fused to the GFP (data not shown). In the case of PABPN1, the
lack of recruitment was also verified with antibodies directed
against the endogenous protein (data not shown). Although it
is still possible that an interaction may actually occur in
unstressed cells, the lack of co-localization argues against
the possibility that these proteins may act as recruiters of
SF2/ASF to nSBs.
Interaction with SatIII sequences
The results in the previous section prompted us to investigate
whether the recruitment to nSBs could reflect the ability of
SF2/ASF to interact with SatIII transcripts through RRM2.
This hypothesis was supported by the fact that the transcribed
strand of the SatIII element (158 nt; GenBank accession no.
X06137) contains four putative high-affinity binding sites for
SF2/ASF identified by the ESEfinder program (http://
exon.cshl.edu/ESE/) (Figure 3). In particular, one of these
(AACACGA at position 88) shows a score higher than the
experimentally verified binding site of SF2/ASF in exon 7 of
the SMN1 gene (4.08 versus 3.76) (35). Therefore, we decided
to challenge in a gel mobility assay, the full-length protein or
different portions of it for their ability to bind an oligoribo-
nucleotide comprising the predicted binding site at position 88
(SatIII oligo). As positive and negative controls, we used (i)
the well-characterized binding site of SF2/ASF in exon 7 of the
SMN1 gene and (ii) the corresponding sequence in the SMN2
gene that differs from SMN1 only for a C to T substitution and
is not recognized by SF2/ASF (35). In agreement with the
hypothesis, GST-SF2/ASF interacted with SatIII and SMN1
but not with SMN2 (Figure 4A). In this assay, the interaction
was completely abrogated upon the deletion of RRM2, indi-
cating a major role of this domain in the ability of SF2/ASF to
bind to its target sites. In contrast, deletion of the RS domain
(DRS mutant) had no detectable effect on binding. Quantifica-
tion of the retarded bands observed with GST-SF2/ASF and
GST-DRS indicated that the relative affinity for SatIII and
SMN1 sequences (11 and 1% of the total oligonucleotide
respectively with GST-ASF/ASF and 8 and 2% with GST-
DRS) paralleled the score values produced by the ESEfinder
program. Finally, no interaction was observed when only the
GST moiety was used (data not shown).
As shown in Figure 1B, the sole RRM2 is sufficient for the
recruitment to nSBs. We wondered whether RRM2 was also
able to bind to the SatIII oligo by itself. The result in Figure 4C
indicates that this is indeed the case. The intensity of the
retarded band, however, was lower than that observed with
GST-SF2/ASF (1.5% versus 11% of total radioactivity) point-
ing to a role of RRM1 in stabilizing the interaction. No inter-
action was instead detected with SMN1 or SMN2 oligos.
Finally, the binding of RRM2 to SatIII was completely abro-
gated by the replacement of the WQD motif in the first a-helix
with three alanines (Figure 4C), a substitution that prevents the
recruitment to nSBs (Figure 2B).
Mutations in RRM2 affect the activity of SF2/ASF in
alternative splicing
The results in the previous section indicate that RRM2 med-
iates the interaction with a motif in the satellite III sequence
that matches the SF2/ASF-binding site consensus. Similar
sequences are found in splicing enhancers recognized and
bound by SF2/ASF (16). It is conceivable, therefore, that
the amino acid substitutions that abrogate the recruitment to
nSBs may also affect the activity of SF2/ASF in alternative
splicing. To explore this possibility, we challenged the wild-
type SF2/ASF and the different mutants described in Figure 2
for their ability to affect the alternative splicing pattern of the
adenoviral E1A transcripts in vivo. As schematically shown in
Figure 5A, splicing of adenoviral E1A pre-mRNA is charac-
terized by the use of three alternative 50 splice sites and results
in the production of three mature molecules known as 13S,
12S and 9S. Overexpression of SF2/ASF strongly increases the
utilization of the 13S 50 splice site and decreases the produc-
tion of 12S and 9S molecules (21,36). HeLa cells were
co-transfected with the E1A minigene and with vectors
driving the expression of SF2/ASF or of different mutants,
all N-terminally tagged with the T7 epitope. After 48 h, total
RNAs were extracted and subjected to RT–PCR to determine
the relative abundance of 13S, 12S and 9S molecules. The
result of this analysis is shown in Figure 5B and in Supple-
mentary Figure 2. In agreement with the previous data (21,36),
overexpression of the wild-type SF2/ASF promoted the pro-
duction of 13S mRNAs with the concomitant reduction in 12S
and 9S molecules. A similar result was observed with SRp40
(see Supplementary Figure 2), another SR factor that is
Figure 3. Putative SF2/ASF binding sites in the transcribed strand of the SatIII
DNA. The SF2/ASF consensus heptamer motif is shown at the top. The
sequence of the putative binding sites identified by the ESEfinder program
is shown below. Numbers on the left refer to the Satellite III sequence (GenBank
accession no. X06137). Motif scores are indicated on the right.
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recruited to nSBs (unpublished data) and contains an atypical
RRM. In contrast, overexpression of SRp20, which contains a
single RRM and is not recruited to nSBs, promoted the pro-
duction of 12S RNA (Supplementary Figure 2). As shown in
Figure 5B and in agreement with the results obtained in other
laboratories (15,37), the ability of SF2/ASF to increase the 13S
level depended on RRM2 and a mutant lacking this domain
(D2) somehow resembled SRp20 in its ability to promote the
production of 9S and 12S molecules. Interestingly, the D1 and
DRS mutants, which lacked RRM1 and the RS domain respect-
ively, behaved similarly to the entire protein pointing to
RRM2 as the major determinant for the activity of SF2/
ASF in alternative splicing (Supplementary Figure 2).
Finally, we tested the SF2/ASF mutants bearing amino acid
substitutions in RRM2 (Figure 5B). All the substitutions in the
b-strands (Y-A, D-R, VV-AA and E-R) had modest effect on
the activity of SF2/ASF and, similarly to the wild-type
protein, increased the production of 13S molecules. A modest
reduction in the SF2/ASF activity was observed with the R-A
mutant in which the arginine residue immediately upstream
of the putative RNP-2 motif was substituted with an alanine.
In contrast, the replacement of three amino acids in the first
a-helix (WQD-AAA) had a drastic effect on E1A splicing
and the protein behaved as the D2 mutant. Thus, the first
a-helix of RRM2 has a major role in the recruitment to
nSBs, in the interaction with high-affinity binding sites, and
in the function of SF2/ASF in the alternative splicing of E1A
transcripts.
DISCUSSION
In this paper, we have studied the recruitment of splicing factor
SF2/ASF to nSBs. The nSBs are intimately connected with
RNA metabolism and in fact, their formation and stability is
affected by transcription inhibitors and by RNAse treatments
(19,38). The link with RNAs is underscored by the recent
finding that satellite III (SatIII) transcripts are stable compo-
nents of nSBs (8,9). This has suggested a model whereby
SatIII RNAs are directly involved in the recruitment of
Figure 4. Mobility shift assay. Equal amounts (15 fmol) of the 50-end labeled oligo-ribonucleotides containing (i) the SF2/ASF site in SMN1 gene, (ii) the
corresponding sequence in the SMN2 gene and (iii) the Satellite III sequence with the highest score were incubated with 4 pmol of GST-SF2/ASF or GST-SF2-
DRRM2 (A) as described in the Materials and Methods. After 20 min, complexes were resolved through a 5% polyacrylamide gel and quantified with a
PhosphorImager apparatus. An image of the gel is shown. The same oligos in (A) were tested with GST-DRS (B) and with GST-RRM2 and GST-RRM2
(WQD-AAA) (C).
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RNA-processing factors, among them SF2/ASF. Here, we
provide evidence in support of this model, and we show
that the atypical RRM2 is necessary and sufficient (i) for
the recruitment to nSBs and (ii) for the interaction of SF2/
ASF with a high-affinity binding site in the Satellite III
sequence.
A central role for RRM2 in the SF2/ASF function
Similar to other splicing factors SF2/ASF, in addition to being
diffusely distributed throughout the nucleoplasm, is concen-
trated in a few specific sub-nuclear compartments known as
nuclear speckles. Targeting these structures requires at least
two of the three domains (RRM1, RRM2 and the RS domain)
of SF2/ASF, implying the existence of additive and redundant
signals for this function. In contrast to this, our analysis indic-
ates that the association with nSBs exclusively relies on
RRM2, which is both necessary and sufficient for the distribu-
tion of SF2/ASF in heat-shocked cells. The physiological role
of the atypical RRM2 domain in the SF2/ASF function is still
elusive. However, several studies have suggested its import-
ance in both RNA-binding specificity and alternative splicing.
In vitro and in vivo studies have led to the isolation of high-
affinity binding sites for SF2/ASF (15,18) and to the identi-
fication of a binding site consensus (16). Notably, sequences
selected by SF2/ASF mutants lacking RRM2 drastically differ
from this consensus (18). SF2/ASF recognizes short degen-
erate sequence motifs (6–8 nt) often located within splicing
enhancers. The interaction with the cognate sites is essential
for the activity of SF2/ASF in exon recognition and for the
ability of this splicing factor to stimulate mRNA translation
(39). A program, called ESEfinder, has been recently devel-
oped which provides a list of ‘high-score motifs’ for SF2/ASF
in sequences of interest (40). By means of this program, we
have identified four putative high-affinity binding sites for
SF2/ASF within the transcribed strand of the satellite III
DNA (158 nt). We have been able to show that at least one
of these sites is, indeed, bound by SF2/ASF and that RRM2 is
both necessary and sufficient for the interaction. This is the
first direct evidence that RRM2 is involved in the binding
specificity of SF2/ASF. The RNA-binding property of
RRM2 appears to be intimately linked to the recruitment to
nSBs. Indeed, the first a-helix of RRM2 is critical for both the
aspects as indicated by behavior of the WQD-AAA substitu-
tion mutant. In contrast, the RRM2 function in the sub-nuclear
distribution of SF2/ASF is not affected by mutations in the
b-strand segments that, on the basis of both structural and
biochemical analysis of RRM domains, are expected to estab-
lish direct contacts with the RNA molecule. It is still possible
that, similar to what was observed with other RRMs, the resi-
dues between b-strands may be involved in the RNA-binding
specificity.
Others have recently investigated the role of RRM2 and of
the heptapeptide in the RNA-binding properties and in the
alternative splicing activity of SF2/ASF (31,41). In agreement
with our results, these authors have shown the central role
of RRM2 in alternative splicing and have demonstrated
the ability of this atypical RRM to interact with RNA. More-
over, the same authors have observed that RRM2 is both
necessary and sufficient to elicit the repressing activity of
SF2/ASF on the IIIa distal 30 splice site of the L1 adenovirus
unit, and the heptapeptide has a critical role in this activity
Figure 5. The role of RRM2 in alternative splicing. (A) A diagram of the E1A pre-mRNA. The alternative 50 splice sites and splicing events that generate 13S, 12S and
9S mRNAs are shown schematically. (B) SF2/ASF or the indicated mutants, all N-terminally tagged with the T7 epitope, were overexpressed in HeLa cells to test the
effect on the splicing pattern of transcripts encoded by the E1A minigene. After 48 h, the RNAs were extracted, subjected to RT–PCR with E1A specific oligos in the
presence of [a-32P]dCTP. The RT–PCR products were resolved through a 5% polyacrylamide gel and quantified with a PhosphorImager apparatus. The histogram
shows the relative amount of 13S, 12S and 9S molecules in cells overexpressing the indicated mutants. The bars represent the average of at least three independent
experiments. D2, SF2/ASF lacking RRM2. V, E1A minigene co-transfected with the empty pCGTHCFFLT7 expression vector. Amino acid substitutions introduced
in SF2/ASF are shown in Figure 2A.
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(31). Contrary to our observations, however, they have found
that the mutation of the heptapeptide does not affect binding of
SF2/ASF to a 115 nt RNA spanning the E1A 13S 50 splice site,
suggesting a role of this sequence in protein–protein interac-
tions. We believe that this discrepancy could originate from
the different assay that is used. These authors, in fact, applied
UV-crosslinking that is suitable to detect even a weak and
transient binding, whereas the mobility shift assay can only
reveal relatively strong and stable interactions. Whether or not
the heptapeptide can mediate protein–protein interactions is
still an open question. In effect, our two-hybrid screening has
selected a number of proteins able to interact with the wild-
type RRM2 but not with the WDQ-AAA mutant. However,
none of these proteins appears to co-localize with SF2/ASF
in nSBs.
Possible function of SatIII transcripts
Our data indicate that the massive recruitment of SF2/ASF to
nSBs is due to the ability of the protein to interact with high-
affinity binding sites that are reiterated in the SatIII transcripts.
Consistent with this, the WQD-AAA mutant remains confined
in nuclear speckles in heat-shocked cells. So far, there are no
indications that the SatIII transcripts are substrates for the
splicing apparatus, and we have never observed an accumula-
tion in nSBs of other proteins or factors critical for the splicing
reaction such as snRNPs (data not shown). We hypothesize
that the function of the non-coding satellite III transcripts is to
sequester a subset of RNA-processing factors thus preventing
their interaction with pre-mRNA molecules.
Our results point to the heptapeptide that forms the first
a-helix of RRM2 as a major determinant in the association
with nSBs and the interaction with SatIII RNAs. Interestingly,
this heptapeptide is perfectly conserved in all the RRM2
domains of SR splicing factors, whereas other residues in
the same domain appear more divergent (Figure 2A).
Although we have not performed an extensive analysis of
the other SR proteins bearing RRM2, the fact that SRp30
(10) and SRp40 (data not shown) are both recruited to
nSBs supports the idea that the association with nSBs is a
common feature of RNA-binding proteins with RRM2, and
is part of the cellular response to heat shock. SR factors have a
major role in alternative splicing and, as recently shown, also
in the export to the cytoplasm and in controlling translation of
mature mRNA (39). Both events are mediated by the interac-
tion of SF2/ASF with high-affinity binding sites in the exonic
sequences. In this perspective, the presence of high-affinity
binding sites in the Satellite III transcripts would lead to the
sequestration of RRM2-containing SR factors and conse-
quently would affect alternative splicing and translation of
a large number of genes.
It has recently been reported that the rapid and transient
inhibition of splicing triggered by heat shock is due to the
dephosphorylation of another SR protein, SRp38, which
sequesters the U1 small nuclear ribonucleoprotein particle
(42). In HeLa cells, this event is completely reverted after
1 h of recovery. However, SF2/ASF is sequestered in nSBs
well beyond this time. Thus, it is conceivable that the restart of
splicing is accompanied by the execution of a specific alter-
native splicing program that relies on the unbalanced distribu-
tion of splicing factors with the prevalence of those not
recruited to nSBs, such as SC-35 and SRp20 (10). We propose
that this could be part of a strategy exploited by human cells to
tune the gene expression program at the post-transcriptional
level during the recovery from stress.
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